Atai life sciences to participate in september investor events

New york and berlin, sept. 07, 2022 (globe newswire) -- atai life sciences n.v. (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following investor conferences in september:
ATAI Ratings Summary
ATAI Quant Ranking